Q-omics provides the consensus-scored LINC00672 profile across patient tissues and cancer cell-line models. LINC00672 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC00672 is differentially expressed in 13, with the highest sampling consensus in KICH. Additionally, LINC00672 RNA expression shows 18,421 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight ACC, KICH, and UVM as cancer lineages where LINC00672 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00672 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00672 survival associations across molecular data types. LINC00672 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00672 RNA expression–survival associations across cancer types. High LINC00672 expression shows unfavorable associations in ACC, OV, MESO and UVM, but favorable associations in LGG and SKCM. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC00672 RNA expression.
This table summarizes LINC00672 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00672. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00672 shows lower tumor expression in KICH, UCEC and LUSC and higher tumor expression in THCA, KIRC and LIHC. The KICH box plot shows higher LINC00672 RNA expression in normal versus tumor tissue (log2 FC = −0.758, t-test p < 0.001).
This table shows molecular features associated with LINC00672 in patient tissues and cancer cell lines. In patient samples, LINC00672 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
